| Date Filed | Type | Description |
| 07/05/2023 |
4
| BERMAN DENNIS N (Director) has filed a Form 4 on Inhibikase Therapeutics, Inc.|
Txns:
| Granted 6,667 options to buy
@ $3.61, valued at
$24.1k
|
|
| 07/05/2023 |
4
| Dion Gisele (Director) has filed a Form 4 on Inhibikase Therapeutics, Inc.|
Txns:
| Granted 6,667 options to buy
@ $3.61, valued at
$24.1k
|
|
| 07/05/2023 |
4
| GRINT PAUL C (Director) has filed a Form 4 on Inhibikase Therapeutics, Inc.|
Txns:
| Granted 6,667 options to buy
@ $3.61, valued at
$24.1k
|
|
| 07/05/2023 |
4
| Freeman Roy Lester (Director) has filed a Form 4 on Inhibikase Therapeutics, Inc.|
Txns:
| Granted 6,667 options to buy
@ $3.61, valued at
$24.1k
|
|
| 09/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/06/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/16/2022 |
4
| Werner Milton H. (President and CEO) has filed a Form 4 on Inhibikase Therapeutics, Inc.|
Txns:
| Bought 5,000 shares
@ $0.8, valued at
$4k
|
|
| 06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/31/2022 |
4
| Werner Milton H. (President and CEO) has filed a Form 4 on Inhibikase Therapeutics, Inc.|
Txns:
| Bought 5,000 shares
@ $0.976, valued at
$4.9k
|
|
| 05/23/2022 |
4
| Werner Milton H. (President and CEO) has filed a Form 4 on Inhibikase Therapeutics, Inc.|
Txns:
| Bought 10,000 shares
@ $0.6, valued at
$6k
|
|
| 05/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/21/2022 |
4
| Werner Milton H. (President and CEO) has filed a Form 4 on Inhibikase Therapeutics, Inc.|
Txns:
| Granted 125,000 options to buy
@ $1.07, valued at
$133.8k
|
|
| 03/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/09/2022 |
4
| Werner Milton H. (President and CEO) has filed a Form 4 on Inhibikase Therapeutics, Inc.|
Txns:
| Granted 125,000 options to buy
@ $1.07, valued at
$133.8k
|
|
| 01/04/2022 |
4
| Werner Milton H. (President and CEO) has filed a Form 4 on Inhibikase Therapeutics, Inc.|
Txns:
| Exercised 21,853 options to buy
@ $2.02, valued at
$44.1k
|
|
| 11/19/2021 |
4
| Werner Milton H. (President and CEO) has filed a Form 4 on Inhibikase Therapeutics, Inc.|
Txns:
| Bought 17,569 shares
@ $1.98, valued at
$34.8k
Bought 1,100 shares
@ $1.97, valued at
$2.2k
Bought 3,186 shares
@ $1.96, valued at
$6.2k
Bought 1,334 shares
@ $1.94, valued at
$2.6k
Bought 400 shares
@ $1.93, valued at
$772 |
|
| 08/19/2021 |
4
| Werner Milton H. (President and CEO) has filed a Form 4 on Inhibikase Therapeutics, Inc.|
Txns:
| Exercised 21,853 options to buy
@ $2.02, valued at
$44.1k
|
|
| 06/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2021 |
4
| Werner Milton H. (President and CEO) has filed a Form 4 on Inhibikase Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 16,918 shares
@ $4.59, valued at
$77.7k
Exercised 43,707 options to buy
@ $0.38, valued at
$16.6k
|
|
| 12/29/2020 |
4
| BERMAN DENNIS N (Director) has filed a Form 4 on Inhibikase Therapeutics, Inc.|
Txns:
| Granted 6,825 options to buy
@ $10, valued at
$68.3k
|
|
| 12/29/2020 |
4
| O'Farrell Elizabeth G. (Director) has filed a Form 4 on Inhibikase Therapeutics, Inc.|
Txns:
| Granted 6,825 options to buy
@ $10, valued at
$68.3k
|
|
| 12/29/2020 |
4
| GRINT PAUL C (Director) has filed a Form 4 on Inhibikase Therapeutics, Inc.|
Txns:
| Granted 6,825 options to buy
@ $10, valued at
$68.3k
|
|
| 12/29/2020 |
4
| Freeman Roy Lester (Director) has filed a Form 4 on Inhibikase Therapeutics, Inc.|
Txns:
| Granted 6,825 options to buy
@ $10, valued at
$68.3k
|
|
| 12/29/2020 |
4
| Werner Milton H. (President and CEO) has filed a Form 4 on Inhibikase Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $10, valued at
$1M
|
|
| 12/29/2020 |
4
| FRATTAROLI JOSEPH (CFO) has filed a Form 4 on Inhibikase Therapeutics, Inc.|
Txns:
| Converted 44,143 shares
@ $10, valued at
$441.4k
Granted 100,000 options to buy
@ $10, valued at
$1M
Converted convertible notes
@ $10, valued at
$0 |
|
| 12/22/2020 |
3
| FRATTAROLI JOSEPH (CFO) has filed a Form 3 on Inhibikase Therapeutics, Inc. |
| 12/22/2020 |
3
| Kalman Daniel (10% Owner) has filed a Form 3 on Inhibikase Therapeutics, Inc. |
|